(Bloomberg) -- Exxon Mobil Corp. is awarding US employees above-inflation pay increases just weeks after the Texas oil giant posted its highest quarterly profit, underlining how strong 2022 has been for the fossil-fuel industry while other sectors like technology and finance cut jobs.Most Read from BloombergPutin Calls Russian Nukes Deterrent Factor, Says War Risk RisingPeru’s President Accused of Coup After Move to Dissolve CongressMusk Spars With San Francisco Over Probe of Bedrooms at Twitter
Heading into next year, a couple of Aristocrats that look to be good investments are Abbott Laboratories (NYSE: ABT) and ExxonMobil (NYSE: XOM). Healthcare giant Abbott Laboratories has a diverse business that generates over $1 billion in revenue every quarter from multiple segments, including medical devices, pharmaceuticals, diagnostics, and nutrition. Abbott has since restarted production and, assuming no interruptions happen again, next year should be a stronger one for that segment as well.
Exxon Mobil, WesBanco, S&T Bancorp, Gilead Sciences and Conagra Brands are included in this Analyst Blog.